Yukio Homma Selected Research

Tyrosine Kinase Inhibitors

11/2014	Granulocyte macrophage colony-stimulating factor as a predictor of the response of metastatic renal cell carcinoma to tyrosine kinase inhibitor therapy.
1/2014	A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma.
1/2011	Development of nephrotic syndrome after administration of sorafenib in a case of metastatic renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukio Homma Research Topics

Disease

60	Neoplasms (Cancer) 01/2021 - 05/2004
54	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 04/2004
22	Carcinoma (Carcinomatosis) 11/2018 - 03/2012
21	Interstitial Cystitis (Interstitial Cystitis, Chronic) 11/2023 - 10/2007
21	Overactive Urinary Bladder (Overactive Bladder) 12/2019 - 05/2005
18	Neoplasm Metastasis (Metastasis) 04/2023 - 05/2004
15	Renal Cell Carcinoma (Grawitz Tumor) 04/2020 - 01/2009
13	Urinary Bladder Neoplasms (Bladder Cancer) 04/2023 - 03/2002
12	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2018 - 06/2004
6	Pain (Aches) 10/2023 - 09/2006
6	Lower Urinary Tract Symptoms 01/2019 - 11/2006
6	Testicular Neoplasms (Testicular Cancer) 04/2016 - 04/2005
5	Inflammation (Inflammations) 11/2023 - 01/2017
5	Urinary Incontinence 01/2019 - 06/2011
4	Disseminated Intravascular Coagulation 05/2023 - 12/2012
4	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2018 - 07/2011
3	Pelvic Pain 11/2023 - 04/2017
3	Hypersensitivity (Allergy) 01/2021 - 05/2016
3	Carcinogenesis 04/2020 - 06/2004
3	Hydronephrosis 10/2017 - 03/2006
3	Insulin Resistance 03/2017 - 05/2011
3	Hypertension (High Blood Pressure) 03/2017 - 03/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2017 - 03/2015
3	Small Cell Carcinoma 01/2017 - 01/2016
3	Nocturia 10/2016 - 01/2002
3	Urinary Retention 03/2015 - 02/2009
3	Adenocarcinoma 01/2015 - 06/2004
3	Body Weight (Weight, Body) 05/2013 - 02/2011
2	Cystitis 11/2023 - 01/2017
2	Fibrosis (Cirrhosis) 01/2021 - 10/2010
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2018 - 01/2013
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2018 - 11/2014
2	Kidney Neoplasms (Kidney Cancer) 03/2017 - 03/2010
2	Melanoma (Melanoma, Malignant) 01/2017 - 04/2016
2	Urologic Neoplasms (Urological Cancer) 01/2017 - 06/2014
2	Infections 12/2016 - 07/2013
2	Polyuria 10/2016 - 09/2013
2	Lymphatic Metastasis 02/2016 - 09/2012

Drug/Important Bio-Agent (IBA)

20	AndrogensIBA 11/2018 - 05/2004
11	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 03/2012
8	Proteins (Proteins, Gene)FDA Link 04/2020 - 12/2010
8	silodosin FDA Link 01/2018 - 11/2006
8	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2010
7	Hormones (Hormone)IBA 01/2019 - 09/2006
6	AntigensIBA 01/2021 - 06/2013
6	mirabegronIBA 12/2019 - 12/2012
6	imidafenacinIBA 05/2017 - 09/2008
6	Docetaxel (Taxotere)FDA Link 04/2016 - 12/2011
5	Messenger RNA (mRNA)IBA 01/2021 - 10/2007
5	Muscarinic AntagonistsIBA 01/2019 - 02/2009
5	Prostate-Specific Antigen (Semenogelase)IBA 05/2018 - 05/2004
5	Cholinergic Antagonists (Anticholinergics)IBA 10/2017 - 10/2009
5	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 09/2013
5	Estrogens (Estrogen)FDA Link 01/2016 - 03/2010
5	CreatinineIBA 11/2014 - 05/2002
4	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 07/2009
4	C-Reactive ProteinIBA 09/2017 - 05/2011
4	Tamsulosin (Flomax)FDA LinkGeneric 12/2013 - 02/2006
3	SolutionsIBA 01/2021 - 11/2013
3	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2016
3	Testosterone (Sustanon)FDA Link 01/2018 - 04/2005
3	Long Noncoding RNAIBA 03/2017 - 06/2013
3	Insulin (Novolin)FDA Link 03/2017 - 03/2015
3	SodiumIBA 03/2017 - 03/2015
3	Hemoglobins (Hemoglobin)IBA 01/2017 - 11/2014
3	Type A Botulinum Toxins (Botox)FDA Link 09/2015 - 06/2011
3	Transcription Factors (Transcription Factor)IBA 02/2015 - 04/2011
3	Tyrosine Kinase InhibitorsIBA 11/2014 - 01/2011
3	Cholinergic Agents (Cholinergics)IBA 04/2014 - 09/2008
3	Indicators and Reagents (Reagents)IBA 01/2014 - 09/2011
3	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2013 - 12/2010
2	InterferonsIBA 11/2023 - 10/2010
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 10/2023 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2021 - 04/2014
2	LipopolysaccharidesIBA 01/2021 - 10/2018
2	CytokinesIBA 01/2019 - 01/2018
2	Peptides (Polypeptides)IBA 01/2019 - 02/2012
2	ChemokinesIBA 01/2018 - 03/2010
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2013
2	Alkaline PhosphataseIBA 01/2017 - 05/2011
2	AlbuminsIBA 01/2017 - 02/2016

Therapy/Procedure

34	Therapeutics 10/2023 - 04/2004
20	Prostatectomy (Retropubic Prostatectomy) 03/2022 - 04/2004
19	Drug Therapy (Chemotherapy) 05/2020 - 03/2002
14	Nephroureterectomy 04/2023 - 03/2006
14	Cystectomy 03/2022 - 01/2013
13	Nephrectomy 04/2023 - 01/2009
7	Intravesical Administration 11/2023 - 03/2002
6	Castration 01/2019 - 01/2012
6	Radiotherapy 06/2017 - 09/2014
5	Immunotherapy 01/2017 - 03/2006
4	Nephrotomy 05/2023 - 03/2006
4	Orchiectomy (Orchidectomy) 11/2016 - 09/2011
3	Renal Dialysis (Hemodialysis) 04/2023 - 10/2013
3	Catheters 05/2017 - 10/2012
3	Oncolytic Virotherapy 01/2017 - 01/2010
2	Neoadjuvant Therapy 02/2018 - 04/2015
2	Adjuvant Chemotherapy 10/2017 - 04/2015
2	Urinary Diversion (Ileal Conduit) 04/2017 - 12/2014
2	Peritoneal Dialysis 12/2016 - 11/2014